CN116261977A - Preferred formula of natural vitamin E imported olive oil (unsaturated fatty acid) with single coenzyme particle content of 45-50 mg - Google Patents
Preferred formula of natural vitamin E imported olive oil (unsaturated fatty acid) with single coenzyme particle content of 45-50 mg Download PDFInfo
- Publication number
- CN116261977A CN116261977A CN202210084267.8A CN202210084267A CN116261977A CN 116261977 A CN116261977 A CN 116261977A CN 202210084267 A CN202210084267 A CN 202210084267A CN 116261977 A CN116261977 A CN 116261977A
- Authority
- CN
- China
- Prior art keywords
- coenzyme
- olive oil
- vitamin
- fatty acid
- imported
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 title claims abstract description 46
- 229930003427 Vitamin E Natural products 0.000 title claims abstract description 23
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 title claims abstract description 23
- 235000019165 vitamin E Nutrition 0.000 title claims abstract description 23
- 229940046009 vitamin E Drugs 0.000 title claims abstract description 23
- 239000011709 vitamin E Substances 0.000 title claims abstract description 23
- 235000008390 olive oil Nutrition 0.000 title claims abstract description 22
- 239000004006 olive oil Substances 0.000 title claims abstract description 22
- 239000005515 coenzyme Substances 0.000 title claims abstract description 18
- 150000004670 unsaturated fatty acids Chemical class 0.000 title claims abstract description 12
- 235000021122 unsaturated fatty acids Nutrition 0.000 title claims abstract description 12
- 239000002245 particle Substances 0.000 title abstract description 6
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 claims abstract description 12
- 235000017471 coenzyme Q10 Nutrition 0.000 claims abstract description 12
- 229940110767 coenzyme Q10 Drugs 0.000 claims abstract description 12
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 claims abstract description 12
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 claims description 6
- 239000008187 granular material Substances 0.000 claims description 5
- 238000002156 mixing Methods 0.000 claims description 5
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 4
- 239000000463 material Substances 0.000 claims description 4
- 238000000034 method Methods 0.000 claims description 4
- 238000002360 preparation method Methods 0.000 claims description 4
- 108010010803 Gelatin Proteins 0.000 claims description 3
- 239000002775 capsule Substances 0.000 claims description 3
- 239000008273 gelatin Substances 0.000 claims description 3
- 229920000159 gelatin Polymers 0.000 claims description 3
- 235000019322 gelatine Nutrition 0.000 claims description 3
- 235000011852 gelatine desserts Nutrition 0.000 claims description 3
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 3
- 239000002994 raw material Substances 0.000 claims description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 3
- 235000013871 bee wax Nutrition 0.000 claims description 2
- 239000012166 beeswax Substances 0.000 claims description 2
- 238000001035 drying Methods 0.000 claims description 2
- 239000000203 mixture Substances 0.000 claims description 2
- 239000008213 purified water Substances 0.000 claims description 2
- 239000004408 titanium dioxide Substances 0.000 claims description 2
- 238000005303 weighing Methods 0.000 claims description 2
- 238000009472 formulation Methods 0.000 claims 1
- NDLPOXTZKUMGOV-UHFFFAOYSA-N oxo(oxoferriooxy)iron hydrate Chemical compound O.O=[Fe]O[Fe]=O NDLPOXTZKUMGOV-UHFFFAOYSA-N 0.000 claims 1
- 239000007901 soft capsule Substances 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 11
- 208000007536 Thrombosis Diseases 0.000 abstract description 7
- 206010003210 Arteriosclerosis Diseases 0.000 abstract description 4
- 230000032683 aging Effects 0.000 abstract description 4
- 208000011775 arteriosclerosis disease Diseases 0.000 abstract description 4
- 210000002216 heart Anatomy 0.000 abstract description 4
- 208000024172 Cardiovascular disease Diseases 0.000 abstract description 3
- 208000026106 cerebrovascular disease Diseases 0.000 abstract description 3
- 230000002526 effect on cardiovascular system Effects 0.000 abstract description 3
- 230000004060 metabolic process Effects 0.000 abstract description 3
- 239000013589 supplement Substances 0.000 abstract description 3
- 206010008190 Cerebrovascular accident Diseases 0.000 abstract description 2
- 102000008946 Fibrinogen Human genes 0.000 abstract description 2
- 108010049003 Fibrinogen Proteins 0.000 abstract description 2
- 206010019280 Heart failures Diseases 0.000 abstract description 2
- 206010020772 Hypertension Diseases 0.000 abstract description 2
- 208000006011 Stroke Diseases 0.000 abstract description 2
- 239000003963 antioxidant agent Substances 0.000 abstract description 2
- 235000006708 antioxidants Nutrition 0.000 abstract description 2
- 206010003119 arrhythmia Diseases 0.000 abstract description 2
- 230000006793 arrhythmia Effects 0.000 abstract description 2
- 230000015572 biosynthetic process Effects 0.000 abstract description 2
- 239000008280 blood Substances 0.000 abstract description 2
- 210000004369 blood Anatomy 0.000 abstract description 2
- 230000002490 cerebral effect Effects 0.000 abstract description 2
- 235000014113 dietary fatty acids Nutrition 0.000 abstract description 2
- 229930195729 fatty acid Natural products 0.000 abstract description 2
- 239000000194 fatty acid Substances 0.000 abstract description 2
- 150000004665 fatty acids Chemical class 0.000 abstract description 2
- 229940012952 fibrinogen Drugs 0.000 abstract description 2
- 201000000585 muscular atrophy Diseases 0.000 abstract description 2
- 208000010125 myocardial infarction Diseases 0.000 abstract description 2
- 230000003647 oxidation Effects 0.000 abstract description 2
- 238000007254 oxidation reaction Methods 0.000 abstract description 2
- 208000024891 symptom Diseases 0.000 abstract description 2
- 238000002560 therapeutic procedure Methods 0.000 abstract description 2
- 230000024883 vasodilation Effects 0.000 abstract description 2
- 229940079593 drug Drugs 0.000 abstract 2
- 239000003814 drug Substances 0.000 abstract 2
- 235000013305 food Nutrition 0.000 abstract 1
- 210000004027 cell Anatomy 0.000 description 8
- 239000000126 substance Substances 0.000 description 5
- 230000006870 function Effects 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 210000004211 gastric acid Anatomy 0.000 description 2
- 230000010247 heart contraction Effects 0.000 description 2
- 208000034783 hypoesthesia Diseases 0.000 description 2
- 210000000987 immune system Anatomy 0.000 description 2
- 230000002438 mitochondrial effect Effects 0.000 description 2
- 235000016709 nutrition Nutrition 0.000 description 2
- 230000035764 nutrition Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 208000024827 Alzheimer disease Diseases 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 208000007882 Gastritis Diseases 0.000 description 1
- 208000016621 Hearing disease Diseases 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- 208000028389 Nerve injury Diseases 0.000 description 1
- 206010038848 Retinal detachment Diseases 0.000 description 1
- 206010039966 Senile dementia Diseases 0.000 description 1
- 230000007815 allergy Effects 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 208000006673 asthma Diseases 0.000 description 1
- 238000010009 beating Methods 0.000 description 1
- 210000000941 bile Anatomy 0.000 description 1
- 210000004413 cardiac myocyte Anatomy 0.000 description 1
- 150000001746 carotenes Chemical class 0.000 description 1
- 235000005473 carotenes Nutrition 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- 230000019522 cellular metabolic process Effects 0.000 description 1
- 230000007547 defect Effects 0.000 description 1
- 230000018044 dehydration Effects 0.000 description 1
- 238000006297 dehydration reaction Methods 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 208000000718 duodenal ulcer Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 230000004438 eyesight Effects 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 230000005802 health problem Effects 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 210000004185 liver Anatomy 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 210000003470 mitochondria Anatomy 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 210000004165 myocardium Anatomy 0.000 description 1
- 230000004379 myopia Effects 0.000 description 1
- 208000001491 myopia Diseases 0.000 description 1
- 230000008764 nerve damage Effects 0.000 description 1
- 231100000862 numbness Toxicity 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 230000037081 physical activity Effects 0.000 description 1
- 230000005195 poor health Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 208000023504 respiratory system disease Diseases 0.000 description 1
- 230000004264 retinal detachment Effects 0.000 description 1
- 201000000980 schizophrenia Diseases 0.000 description 1
- 230000028327 secretion Effects 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 210000003491 skin Anatomy 0.000 description 1
- 210000004927 skin cell Anatomy 0.000 description 1
- 230000037394 skin elasticity Effects 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- SOECUQMRSRVZQQ-UHFFFAOYSA-N ubiquinone-1 Chemical compound COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O SOECUQMRSRVZQQ-UHFFFAOYSA-N 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 230000037303 wrinkles Effects 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/115—Fatty acids or derivatives thereof; Fats or oils
- A23L33/12—Fatty acids or derivatives thereof
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23P—SHAPING OR WORKING OF FOODSTUFFS, NOT FULLY COVERED BY A SINGLE OTHER SUBCLASS
- A23P10/00—Shaping or working of foodstuffs characterised by the products
- A23P10/30—Encapsulation of particles, e.g. foodstuff additives
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Mycology (AREA)
- Health & Medical Sciences (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
The invention relates to a preferable formula of natural vitamin E imported olive oil (unsaturated fatty acid) with single coenzyme particle content of 45-50 mg. Coenzyme Q10, olive oil and vitamin E are all antioxidants, and supplement each other, so that the aging caused by oxidation can be prevented, the change speed of the medicines can be slowed down, the medicines can be used for providing power for the heart, and the symptoms such as arrhythmia heart failure, arteriosclerosis, heart attack, cerebral apoplexy, hypertension or muscular atrophy can be improved. Vitamin E has the function of reducing thrombosis, and can be properly supplemented to reduce the risk of suffering from cardiovascular and cerebrovascular diseases. Vitamin E is supplemented, so that the vasodilation can be promoted, the fat metabolism speed can be increased, the blood viscosity can be reduced, and arteriosclerosis is not easy to occur. The olive oil has the effect of reducing thrombus, and the fatty acid a3 in the olive oil can reduce the viscosity of platelets and reduce the amount of fibrinogen, so that the probability of thrombus formation is greatly reduced. The invention optimizes the proportion combination through reasonable component content proportion so as to achieve better food therapy effect.
Description
Technical Field
The invention relates to a preferable formula of natural vitamin E imported olive oil (unsaturated fatty acid) with single coenzyme particle content of 45-50 mg.
Background
In 1957, the first successful separation of a new pure product from the mitochondrial lipid extract of cardiomyocytes in bovine heart by the doctor of university of wisconsin, which is a substance known by medical practitioners as a source of "cell energy", namely what we now call coenzyme Q10, coenzyme Q10 being a non-vitamin nutrient substance, which is present in the mitochondria of the energy processing plant of cells, "coenzyme 10" being an important production member of the energy processing plant of cells, is the main participant of energy production in the energy processing plant of cells, "coenzyme 10 being involved in the energy produced called triphosphate, namely what we commonly say ATP, which is an energy source necessary for cell growth, is the energy basis of heart beating; is the power of human body activity, the coenzyme 10 strengthens the metabolism of cardiac muscle, improves the efficiency of heart beating, ensures the normal life activity of the human body, stops beating without the coenzyme 10, and ends the life. Coenzyme Q10 is a component of cells naturally occurring in our body, it is present on the mitochondrial inner membrane of cells in our body, it is an important substance for regulating cell metabolism in our body, it is a source of force for supplying energy and vitality to cells in our body, it is one of the heaviest components in our body. It is also an important element that directly affects the immune system of the body and the aging process; if the coenzyme Q10 is lacking in the human body, the body can have a plurality of health problems, such as arrhythmia heart failure, arteriosclerosis, heart attack, cerebral apoplexy, hypertension or muscular atrophy and other symptoms. In experimental and clinical studies over the last decades, the administration of coenzyme Q1 has been shown to be helpful for allergies, asthma, respiratory diseases, hearing disorders, etc. There are also reports that coenzyme Q10 can ameliorate some of the brain disorders associated with schizophrenia and senile dementia; the coenzyme Q10 capsules in the current market have low efficacy content and poor health care effect, and are necessary to be improved.
The invention aims to prepare a coenzyme Q10 optimized diet therapy formula with optimal efficacy by adopting a brand new reasonable scientific formula according to the modern nutrition theory. The coenzyme Q10 and substances required by heart nutrition are rapidly supplemented, so that the immunity of organisms can be improved, the normal functions of important organs such as heart, liver, lung and stomach are maintained, and the prevention of senile cardiovascular and cerebrovascular diseases is more important especially for the aged and people with reduced immune systems.
The method adopts an advanced production process and the most advanced microbial fermentation method, and ensures the activity of enzyme through ultralow-temperature purification; the scientific compatibility is easy to absorb; the efficacy of the prescription is confirmed.
The vitamin E has excellent effect of reducing oxidation, can delay the aging of skin cells and reduce the risk of skin dehydration, thereby keeping skin elasticity and slowing down the wrinkle generation. The elderly can supplement vitamin E and improve numbness of limbs. The vitamin E has the effects of protecting cells, relieving nerve injury caused by various reasons, improving activity of muscle tissues and joints, delaying tissue aging, keeping hands and feet as flexible as possible, and relieving numbness and stiffness; vitamin E has effects of reducing thrombosis, and can be properly supplemented to reduce risk of cardiovascular and cerebrovascular diseases. Vitamin E is supplemented, so that the vasodilation can be promoted, the fat metabolism speed can be increased, the blood viscosity can be reduced, and arteriosclerosis is not easy to occur. The myopia people can supplement vitamin E, can improve the internal circulation of eyes, and has the effect of protecting eyesight. Vitamin E also protects the lens and reduces the risk of retinal detachment.
The olive oil can reduce thrombosis probability, reduce gastric acid, stimulate bile secretion, and relax bowel. The olive oil firstly has the function of reducing thrombus, because the alpha 3 fatty acid in the olive oil can reduce the viscosity of platelets and reduce the amount of fibrinogen, thus greatly reducing the probability of thrombus formation, in addition, the olive oil can improve the functions of the digestive system, and the olive oil contains higher unsaturated fatty acids, a plurality of carotenes, fat-soluble vitamins, a plurality of antioxidant substances and other components which are easy to be absorbed by human bodies, so the olive oil has the functions of reducing gastric acid, preventing gastritis and duodenal ulcer.
Disclosure of Invention
In order to overcome the defects and shortcomings of the existing coenzyme Q10 replenisher in the factors such as single effect of the composition variety, unreasonable collocation and the like; the invention aims to provide a preferable formula of natural vitamin E imported olive oil (unsaturated fatty acid) with single coenzyme particle content of 45-50 mg.
The aim of the invention is achieved by the following technical scheme:
a preferred formula of natural vitamin E imported olive oil (unsaturated fatty acid) with single coenzyme content of 45-50 mg is prepared, wherein each content comprises the following components: main materials: coenzyme Q10, wherein each 100 functional components contain 45-50 mg of coenzyme and auxiliary materials: olive oil, gelatin, purified water, glycerol, beeswax, titanium dioxide, iron oxide yellow, vitamin E and the like are added according to the weight of single granules and the national standard.
The preferred formula of the natural vitamin E imported olive oil (unsaturated fatty acid) with the single coenzyme particle content of 45-50 mg comprises the following steps:
preparation of the content: and (5) weighing the raw materials of the content according to the formula amount, and uniformly mixing to obtain the content.
The preparation after uniform mixing mainly comprises the following steps: mixing, drying, encapsulating, and bottling.
The preferential formula preparation of the natural vitamin E imported olive oil (unsaturated fatty acid) with the single coenzyme content of 45-50 mg is taken by 1 granule of warm water every day according to adults, the shelf life is more than 24 months, and the product stability is strong.
In addition, the invention may be embodied in other forms and any obvious substitutions may be made without departing from the spirit of the invention.
Claims (3)
1. A preferred formula of natural vitamin E imported olive oil (unsaturated fatty acid) with a coenzyme single grain content of 45-50 mg, wherein each grain of the content comprises: main materials: coenzyme Q10, wherein each 100 functional components contain 45-50 mg of coenzyme and auxiliary materials: olive oil, gelatin, purified water, glycerol, beeswax, titanium dioxide, yellow ferric oxide, vitamin E and the like are added according to the weight of single granules and the national standard.
2. The method of claim 1: the optimized formula of the natural vitamin E imported olive oil (unsaturated fatty acid) with single coenzyme content of 45-50 mg is prepared by weighing the raw materials of the content according to the formula amount, uniformly mixing the raw materials to obtain the content, and filling the uniformly mixed preparation into a gelatin hollow capsule by a capsule machine; the method mainly comprises the following steps: mixing, pelleting, drying, bottling, etc. to obtain 2.
3. The preferred formulation of the coenzyme single granule of claim 2, wherein the content of the coenzyme single granule is 45-50 mg, and the natural vitamin E imported olive oil (unsaturated fatty acid) is soft capsule 3.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210084267.8A CN116261977A (en) | 2022-01-25 | 2022-01-25 | Preferred formula of natural vitamin E imported olive oil (unsaturated fatty acid) with single coenzyme particle content of 45-50 mg |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202210084267.8A CN116261977A (en) | 2022-01-25 | 2022-01-25 | Preferred formula of natural vitamin E imported olive oil (unsaturated fatty acid) with single coenzyme particle content of 45-50 mg |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN116261977A true CN116261977A (en) | 2023-06-16 |
Family
ID=86722752
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202210084267.8A Pending CN116261977A (en) | 2022-01-25 | 2022-01-25 | Preferred formula of natural vitamin E imported olive oil (unsaturated fatty acid) with single coenzyme particle content of 45-50 mg |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN116261977A (en) |
-
2022
- 2022-01-25 CN CN202210084267.8A patent/CN116261977A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US20090110674A1 (en) | Health supplement | |
| CN101589808A (en) | The beverage preparation that contains curcumin extraction | |
| CN103238897A (en) | Composite plant solid drink suitable for diabetic patients | |
| CN111990463A (en) | Bovine colostrum composite powder | |
| CN1788590A (en) | Dairy product or drink for resisting oxidation, regulating blood , nursing heart and delaying aging | |
| CN107136511A (en) | A kind of peony seed oil composition for promoting cranial nerve development, Peony-seed-oil soft capsule and preparation method thereof | |
| CN1947600A (en) | Sun-rays proof beauty-care beverage | |
| CN106418545A (en) | Functional food with balanced nutrients | |
| CN105124347A (en) | Moringa oleifera blood-glucose-reducing composition and preparation method thereof | |
| EP2859896A1 (en) | Pharmaceutical compositions for the treatment of muscular disorders | |
| CN111771988A (en) | Nutritional food suitable for diabetic patients and preparation method thereof | |
| CN109601680A (en) | A kind of maintenance joint and the Astaxanthin In Haematococcus Pluvialis pressed candy of connective tissue health and preparation method thereof | |
| CN105249440A (en) | Donkey-hide gelatin cake | |
| CN112869073A (en) | Chinese medicinal composition comprising fruits and vegetables for improving human body function and removing harmful toxin, and its preparation method | |
| CN102078016A (en) | Glossy ganoderma and Chinese yam beverage and preparation method thereof | |
| RU2283124C1 (en) | Biologically active preparation based on marine vegetable raw | |
| CN107028169A (en) | A kind of composition for improving memory and preparation method thereof | |
| CN116261977A (en) | Preferred formula of natural vitamin E imported olive oil (unsaturated fatty acid) with single coenzyme particle content of 45-50 mg | |
| CN116076710A (en) | Rose herbal ferment with anti-aging and whitening functions and preparation method and application thereof | |
| CN103621871B (en) | Compound amino acid health-care product and preparation method thereof | |
| CN116114887A (en) | Composite double-protein composition and preparation method thereof | |
| CN102763845A (en) | Seabuckthorn fruit oil and propolis soft capsule | |
| CN102771794A (en) | Soft capsule made of seabuckthorn oil and vitamins EC | |
| CN113662044A (en) | Child formula milk powder for promoting height development and enhancing immunity and preparation method thereof | |
| KR20100008400A (en) | The composition for the atopic dermatitis improving with vinegar |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication |